OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.400
-0.040 (-2.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.380
-0.020 (-1.43%)
Pre-market: Apr 29, 2026, 7:00 AM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $202.70 million as of April 29, 2026. Its market cap has decreased by -14.01% in one year.
Market Cap
202.70M
Enterprise Value
169.00M
1-Year Change
-14.01%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $202.70M, a decrease of -79.59%. That is a compound annual growth rate of -36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 202.70M | -23.89% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 226.48M |
| ALX Oncology Holdings | 223.37M |
| Keros Therapeutics | 223.20M |
| Achieve Life Sciences | 220.41M |
| Replimune Group | 218.82M |
| Elicio Therapeutics | 215.05M |
| MediWound | 214.89M |
| Enlivex | 210.98M |